Resultats de la cerca - Michael Bonelli

Refinar resultats
  1. 1
    Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases

    Type I/II cytokines, JAKs, and new strategies for treating autoimmune diseases per Daniella M. Schwartz, Michael Bonelli, Massimo Gadina, John J. O’Shea

    Publicat 2015
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  2. 2
    Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus

    Phenotypic and Functional Analysis of CD4+CD25−Foxp3+ T Cells in Patients with Systemic Lupus Erythematosus per Michael Bonelli, A Savitskaya, Carl-Walter Steiner, Eva Rath, Josef S Smolen, Clemens Scheinecker

    Publicat 2009
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  3. 3
    Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1

    Strain-Specific Properties and T Cells Regulate the Susceptibility to Papilloma Induction by Mus musculus Papillomavirus 1 per Alessandra Handisurya, Patricia M. Day, Cynthia D. Thompson, Michael Bonelli, Douglas R. Lowy, John T. Schiller

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  4. 4
    Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE)

    Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE) per Michael Bonelli, Anastasya Savitskaya, K Dalwigk, C. W. Steiner, Daniel Aletaha, Josef S Smolen, Clemens Scheinecker

    Publicat 2008
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  5. 5
    CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis?

    CD4+CD25-Foxp3+ T cells: a marker for lupus nephritis? per Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Carl-Walter Steiner, G Steiner, Josef S Smolen, Clemens Scheinecker

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  6. 6
    Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis

    Abatacept (CTLA-4Ig) treatment reduces T cell apoptosis and regulatory T cell suppression in patients with rheumatoid arthritis per Michael Bonelli, Lisa Göschl, Stephan Blüml, Thomas Karonitsch, Kiyoshi Hirahara, Elisabeth Ferner, Carl-Walter Steiner, G Steiner, Josef S Smolen, Clemens Scheinecker

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  7. 7
    Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs

    Translational and clinical advances in JAK-STAT biology: The present and future of jakinibs per Massimo Gadina, Catrina Johnson, Daniella M. Schwartz, Michael Bonelli, Sarfaraz Hasni, Yuka Kanno, Paul S. Changelian, Arian Laurence, John J. O’Shea

    Publicat 2018
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  8. 8
    Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story

    Selectivity, efficacy and safety of JAKinibs: new evidence for a still evolving story per Michael Bonelli, Andreas Kerschbaumer, Kastriot Kastrati, Kamran Ghoreschi, Massimo Gadina, Leonhard X. Heinz, Josef S Smolen, Daniel Aletaha, John J. O’Shea, Arian Laurence

    Publicat 2023
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  9. 9
    Helper T Cell Plasticity: Impact of Extrinsic and Intrinsic Signals on Transcriptomes and Epigenomes

    Helper T Cell Plasticity: Impact of Extrinsic and Intrinsic Signals on Transcriptomes and Epigenomes per Michael Bonelli, Han‐Yu Shih, Kiyoshi Hirahara, Kentner Singelton, Arian Laurence, Amanda C. Poholek, Tim Hand, Yohei Mikami, Golnaz Vahedi, Yuka Kanno, John J. O’Shea

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  10. 10
    Transcriptional and epigenetic networks of helper T and innate lymphoid cells

    Transcriptional and epigenetic networks of helper T and innate lymphoid cells per Han‐Yu Shih, Giuseppe Sciumè, Amanda C. Poholek, Golnaz Vahedi, Kiyoshi Hirahara, Alejandro V. Villarino, Michael Bonelli, Rémy Bosselut, Yuka Kanno, Stefan A. Muljo, John J. O’Shea

    Publicat 2014
    Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  11. 11
    Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis

    Abatacept (CTLA‐4IG) treatment reduces the migratory capacity of monocytes in patients with rheumatoid arthritis per Michael Bonelli, Elisabeth Ferner, Lisa Göschl, Stephan Blüml, Anastasiya Hladik, Thomas Karonitsch, H. Kiener, Ruth A. Byrne, Birgit Niederreiter, C. W. Steiner, Eva Rath, Michael Bergmann, Josef S Smolen, Clemens Scheinecker

    Publicat 2012
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  12. 12
    EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion

    EZH2 is crucial for both differentiation of regulatory T cells and T effector cell expansion per Xiang‐Ping Yang, Kan Jiang, Kiyoshi Hirahara, Golnaz Vahedi, Behdad Afzali, Giuseppe Sciumè, Michael Bonelli, Hong‐Wei Sun, Dragana Janković, Yuka Kanno, Vittorio Sartorelli, John J. O’Shea, Arian Laurence

    Publicat 2015
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  13. 13
    Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions

    Signal transducer and activator of transcription 5 (STAT5) paralog dose governs T cell effector and regulatory functions per Alejandro V. Villarino, Arian Laurence, Gertraud W. Robinson, Michael Bonelli, Bárbara Dema, Behdad Afzali, Han‐Yu Shih, Hong‐Wei Sun, Stephen R. Brooks, Lothar Hennighausen, Yuka Kanno, John J. O’Shea

    Publicat 2016
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  14. 14
    IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes

    IRF1 is critical for the TNF-driven interferon response in rheumatoid fibroblast-like synoviocytes per Michael Bonelli, K Dalwigk, Alexander Platzer, Isabel Olmos Calvo, Silvia Hayer, Birgit Niederreiter, Johannes Holinka, Florian Sevelda, Thomas Pap, G Steiner, Giulio Superti‐Furga, Josef S Smolen, Hans P. Kiener, Thomas Karonitsch

    Publicat 2019
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  15. 15
    Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis

    Autoreactive IgE Is Prevalent in Systemic Lupus Erythematosus and Is Associated with Increased Disease Activity and Nephritis per Bárbara Dema, Christophe Pellefigues, Sarfaraz Hasni, Nathalie Gault, Chao Jiang, Tiffany K. Ricks, Michael Bonelli, Jörg Scheffel, Karim Sacré, Mathieu Jablonski, Delphine Gobert, T. Papo, Éric Daugas, Gabor G. Illei, Nicolas Charles, Juan Rivera

    Publicat 2014
    Obtenir text complet Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  16. 16
    Preclinical models of arthritis for studying immunotherapy and immune tolerance

    Preclinical models of arthritis for studying immunotherapy and immune tolerance per Gavin R. Meehan, Ranjeny Thomas, Shaima Al‐Khabouri, Pascale Wehr, Catharien M. U. Hilkens, David C. Wraith, Daniela Sieghart, Michael Bonelli, György Nagy, Paul Garside, David F. Tough, Huw D. Lewis, James M. Brewer

    Publicat 2021
    Obtenir text complet Obtenir text complet
    Revisão
    Afegir a favorits
    Guardat en:
  17. 17
    Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers

    Reduced immunogenicity of BNT162b2 booster vaccination in combination with a tetravalent influenza vaccination: results of a prospective cohort study in 838 health workers per Helga Radner, Daniela Sieghart, Anselm Jorda, Clemens Fedrizzi, Timothy Hasenöhrl, Andrej Zdravkovic, Monika Redlberger‐Fritz, Elisabeth Puchammer-Stoeckl, Karolina Anderle, Felix Bergmann, Christa Firbas, Galateja Jordakieva, Barbara Wagner, Helmuth Haslacher, Thomas Perkmann, Leonhard X. Heinz, Michael Bonelli, Richard Crevenna, Daniel Aletaha, Markus Zeitlinger

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  18. 18
    Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity

    Asymmetric Action of STAT Transcription Factors Drives Transcriptional Outputs and Cytokine Specificity per Kiyoshi Hirahara, Atsushi Onodera, Alejandro V. Villarino, Michael Bonelli, Giuseppe Sciumè, Arian Laurence, Hong‐Wei Sun, Stephen R. Brooks, Golnaz Vahedi, Han‐Yu Shih, Gustavo Gutierrez-Cruz, S. Iwata, Ryo Suzuki, Yohei Mikami, Yoshitaka Okamoto, Toshinori Nakayama, Steven M. Holland, Christopher A. Hunter, Yuka Kanno, John J. O’Shea

    Publicat 2015
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  19. 19
    MicroRNA-146a governs fibroblast activation and joint pathology in arthritis

    MicroRNA-146a governs fibroblast activation and joint pathology in arthritis per Victoria Saferding, Antonia Puchner, Eliana Gonçalves‐Alves, Melanie Hofmann, Michael Bonelli, Julia Brunner, Emine Sahin, Birgit Niederreiter, Silvia Hayer, Hans P. Kiener, Elisa Einwallner, Ramzi Nehmar, Raphaël Carapito, Philippe Georgel, Marije I. Koenders, Mark Boldin, Gernot Schabbauer, Mariola Kurowska‐Stolarska, G Steiner, Josef S Smolen, Kurt Redlich, Stephan Blüml

    Publicat 2017
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:
  20. 20
    Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study

    Immunogenicity and safety of a fourth COVID-19 vaccination in rituximab-treated patients: an open-label extension study per Daniel Mrak, Elisabeth Simader, Daniela Sieghart, Péter Mandl, Helga Radner, Thomas Perkmann, Helmuth Haslacher, Margareta Mayer, Maximilian Koblischke, Philipp Hofer, Lisa Göschl, Felix Kartnig, Thomas Deimel, Andreas Kerschbaumer, Thomas Hummel, Barbara Kornek, Renate Thalhammer, Karin Stiasny, Stefan Winkler, Josef S Smolen, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

    Publicat 2022
    Obtenir text complet
    Artigo
    Afegir a favorits
    Guardat en:

Eines de cerca: